Quadruplet regimen for newly diagnosed multiple myeloma is effective in the standard-risk subgroup but not in the high-risk subgroup

• Jianghua Ding,
• Shengping Gong

Affiliations

Jianghua Ding

Department of Hematology and Oncology, Jiujiang University Affiliated Hospital, Jiujiang, China

Shengping Gong

Department of Oncology, The First Affiliated Hospital of Ningbo University, Ningbo, China